Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 61.33 CNY -5.5% Market Closed
Market Cap: 45.5B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Hangzhou Tigermed Consulting Co Ltd stock under the Base Case scenario is 97.62 CNY. Compared to the current market price of 61.33 CNY, Hangzhou Tigermed Consulting Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
97.62 CNY
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.7
P/S
P/S
Price to Sales
6.7
vs History
73
vs Industry
30
Median 3Y
9.3
Median 5Y
12.6
Industry
4
Forward
6
More Details
47.5
P/E
P/E
Price to Earnings
47.5
vs History
36
vs Industry
27
Median 3Y
26.6
Median 5Y
42.1
Industry
32.2
Forward
33.6
More Details
43.1
P/OCF
P/OCF
Price to OCF
43.1
vs History
65
vs Industry
16
Median 3Y
44.5
Median 5Y
62.3
Industry
21.7
More Details
37.7
P/FCFE
P/FCFE
Price to FCFE
37.7
vs History
39
vs Industry
23
Median 3Y
28
Median 5Y
33.6
Industry
34.2
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
79
vs Industry
51
Median 3Y
3.4
Median 5Y
4.3
Industry
2.6
More Details
6.7
EV/S
EV/S
Enterprise Value to Sales
6.7
vs History
73
vs Industry
33
Median 3Y
8.6
Median 5Y
11.6
Industry
3.8
Forward
6.1
More Details
18.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
18.3
vs History
73
vs Industry
24
Median 3Y
21.9
Median 5Y
29.3
Industry
8.3
More Details
33.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.8
vs History
66
vs Industry
20
Median 3Y
35.1
Median 5Y
46.3
Industry
18.6
Forward
23.6
More Details
33.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
33.8
vs History
66
vs Industry
24
Median 3Y
35.1
Median 5Y
46.3
Industry
23.2
Forward
24.9
More Details
43.4
EV/OCF
EV/OCF
Enterprise Value to OCF
43.4
vs History
65
vs Industry
19
Median 3Y
41.9
Median 5Y
58.4
Industry
20.7
More Details
67.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
67.7
vs History
60
vs Industry
15
Median 3Y
64.2
Median 5Y
87.3
Industry
28.4
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
82
vs Industry
50
Median 3Y
3.1
Median 5Y
4.2
Industry
2.3
More Details

Multiples Across Competitors

Competitors Multiples
Hangzhou Tigermed Consulting Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
45.5B CNY 6.7 47.5 33.8 33.8
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 461.9 4 943.2 1 559.9 3 324.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
196.3B USD 4.6 32 20.8 29.8
US
Danaher Corp
NYSE:DHR
170.3B USD 8 43.8 27.4 41.2
KR
Samsung Biologics Co Ltd
KRX:207940
66.5T KRW 15.8 64.6 34.7 49.7
CH
Lonza Group AG
SIX:LONN
37.6B CHF 5.6 65.6 44.4 44.4
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 27.2 21.4 24.7
US
IQVIA Holdings Inc
NYSE:IQV
36.7B USD 2.4 26.1 14.3 21.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD 7 33.2 23.8 26.6
US
West Pharmaceutical Services Inc
NYSE:WST
23B USD 8 45.9 30.8 38.7
US
Illumina Inc
NASDAQ:ILMN
22.3B USD 5.1 -14.1 31.7 67.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.